245 related articles for article (PubMed ID: 14527775)
1. Pivmecillinam--therapy of choice for lower urinary tract infection.
Graninger W
Int J Antimicrob Agents; 2003 Oct; 22 Suppl 2():73-8. PubMed ID: 14527775
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility to mecillinam of Escherichia coli strains isolated from the urine of pregnant women.
Duployez C; Loiez C; Cattoen C; Descamps D; Wallet F; Vachée A;
Med Mal Infect; 2016 Dec; 46(8):436-441. PubMed ID: 27609597
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Titelman E; Iversen A; Kalin M; Giske CG
Microb Drug Resist; 2012 Apr; 18(2):189-92. PubMed ID: 22204597
[TBL] [Abstract][Full Text] [Related]
5. Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial.
Bjerrum L; Gahrn-Hansen B; Grinsted P
Scand J Prim Health Care; 2009; 27(1):6-11. PubMed ID: 18991182
[TBL] [Abstract][Full Text] [Related]
6. Pivmecillinam in the treatment of urinary tract infections.
Nicolle LE
J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():35-9; discussion 63-5. PubMed ID: 11051622
[TBL] [Abstract][Full Text] [Related]
7. Pivmecillinam for the treatment of acute uncomplicated urinary infection.
Nicolle LE
Int J Clin Pract; 1999 Dec; 53(8):612-7. PubMed ID: 10692756
[TBL] [Abstract][Full Text] [Related]
8. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections.
Jansåker F; Frimodt-Møller N; Sjögren I; Dahl Knudsen J
J Antimicrob Chemother; 2014 Mar; 69(3):769-72. PubMed ID: 24107388
[TBL] [Abstract][Full Text] [Related]
9. Emerging clinical role of pivmecillinam in the treatment of urinary tract infections caused by Extended Spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
Raja NS
Int J Clin Pract; 2019 Sep; 73(9):1-5. PubMed ID: 31243859
[TBL] [Abstract][Full Text] [Related]
10. Microbial risk factors for treatment failure of pivmecillinam in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.
Syre H; Hetland MAK; Bernhoff E; Bollestad M; Grude N; Simonsen GS; Löhr IH
APMIS; 2020 Mar; 128(3):232-241. PubMed ID: 31755584
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of pivmecillinam in oral step-down treatment in hospitalised patients with E. coli bacteremic urinary tract infection; a single-arm, uncontrolled treatment study.
Hansen BÅ; Grude N; Lindbæk M; Stenstad T
BMC Infect Dis; 2022 May; 22(1):478. PubMed ID: 35590284
[TBL] [Abstract][Full Text] [Related]
12. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].
Wagenlehner FM; Schmiemann G; Hoyme U; Fünfstück R; Hummers-Pradier E; Kaase M; Kniehl E; Selbach I; Sester U; Vahlensieck W; Watermann D; Naber KG
Urologe A; 2011 Feb; 50(2):153-69. PubMed ID: 21312083
[TBL] [Abstract][Full Text] [Related]
13. Mutational change of CTX-M-15 to CTX-M-127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient.
Nielsen KL; Hansen KH; Nielsen JB; Knudsen JD; Schønning K; Frimodt-Møller N; Hertz FB; Jansåker F
Microbiologyopen; 2019 Dec; 8(12):e941. PubMed ID: 31573735
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection.
Menday AP
Int J Antimicrob Agents; 2000 Jan; 13(3):183-7. PubMed ID: 10724022
[TBL] [Abstract][Full Text] [Related]
15. Mecillinam resistance and outcome of pivmecillinam treatment in uncomplicated lower urinary tract infection in women.
Monsen TJ; Holm SE; Ferry BM; Ferry SA
APMIS; 2014 Apr; 122(4):317-23. PubMed ID: 24738161
[TBL] [Abstract][Full Text] [Related]
16. The comeback of trimethoprim in France.
Caron F; Wehrle V; Etienne M
Med Mal Infect; 2017 Jun; 47(4):253-260. PubMed ID: 28043762
[TBL] [Abstract][Full Text] [Related]
17. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women.
Nicolle LE; Madsen KS; Debeeck GO; Blochlinger E; Borrild N; Bru JP; Mckinnon C; O'Doherty B; Spiegel W; Van Balen FA; Menday P
Scand J Infect Dis; 2002; 34(7):487-92. PubMed ID: 12195873
[TBL] [Abstract][Full Text] [Related]
18. Pivmecillinam, the paradigm of an antibiotic with low resistance rates in Escherichia coli urine isolates despite high consumption.
Frimodt-Møller N; Simonsen GS; Larsen AR; Kahlmeter G
J Antimicrob Chemother; 2022 Dec; 78(1):289-295. PubMed ID: 36441168
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies on pivmecillinam in urinary tract infections (author's transl)].
Amano M; Kiuchi H; Suzuki M; Morinaga O; Tanaka H
Jpn J Antibiot; 1979 Sep; 32(9):877-82. PubMed ID: 228097
[TBL] [Abstract][Full Text] [Related]
20. Serum estriol level during treatment with pivmecillinam.
Kjer JJ
Acta Obstet Gynecol Scand; 1983; 62(2):153-4. PubMed ID: 6306983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
